SEC Form 4 · accession 0001209191-15-012032
Auspex Pharmaceuticals, Inc. · ASPX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
A later amendment supersedes this filing — read the amendment. The figures below are kept as originally reported (version chain, not an overwrite).
Period of report
Feb 9, 2015
Accepted (ET)
Feb 11, 2015 · 5:03 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001454189
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Feb 9, 2015 | S | 9,608 | $59.00 | D | 3,157,563 | D | |
| Common Stock | Feb 10, 2015 | S | 20,670 | $60.05 | D | 3,163,893 | D | |
| Common Stock | Feb 11, 2015 | S | 51,773 | $61.84 | D | 3,112,120 | D | |
| Common Stock | Feb 9, 2015 | S | 246 | $59.00 | D | 81,014 | I | By: CMEA Ventures VII (Parallel) LP |
| Common Stock | Feb 10, 2015 | S | 530 | $60.05 | D | 80,484 | I | By: CMEA Ventures VII (Parallel) LP |
| Common Stock | Feb 11, 2015 | S | 1,327 | $61.84 | D | 79,157 | D |
Table II — derivative securities
No Table II lines on this filing.